Wegovy received FDA approval on June 4, 2021, making it available to patients for over three years
For tirzepatide, the starting dose is 2.5 mg weekly, increasing through 5 mg, 7.5 mg, 10 mg, 12.5 mg, and up to 15 mg
Note that lower doses also tend to produce fewer side effects overall, which is one of the reasons that using a CGM to optimize what the medication is doing metabolically (so you may not need as high a dose for as long) is increasingly being discussed in clinical contexts
To date, Amazon claims to have saved customers over $200 million through this automated coupon routing, with GLP-1s representing the largest category of savings
Rehabilitation can help restore function and increase muscle